{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:20:47Z","timestamp":1774988447214,"version":"3.50.1"},"reference-count":25,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigacion Sanitaria","award":["PI16\/00503"],"award-info":[{"award-number":["PI16\/00503"]}]},{"name":"Fondo de Investigacion Sanitaria","award":["PI19\/01337"],"award-info":[{"award-number":["PI19\/01337"]}]},{"name":"Fondo de Investigacion Sanitaria","award":["PI20\/00326"],"award-info":[{"award-number":["PI20\/00326"]}]},{"name":"Fondo de Investigacion Sanitaria","award":["2017SGR948"],"award-info":[{"award-number":["2017SGR948"]}]},{"name":"Fondo de Investigacion Sanitaria","award":["RD16\/0025\/0006"],"award-info":[{"award-number":["RD16\/0025\/0006"]}]},{"name":"Fondo de Investigacion Sanitaria","award":["CB21\/13\/00020"],"award-info":[{"award-number":["CB21\/13\/00020"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["PI16\/00503"],"award-info":[{"award-number":["PI16\/00503"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["PI19\/01337"],"award-info":[{"award-number":["PI19\/01337"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["PI20\/00326"],"award-info":[{"award-number":["PI20\/00326"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["2017SGR948"],"award-info":[{"award-number":["2017SGR948"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["RD16\/0025\/0006"],"award-info":[{"award-number":["RD16\/0025\/0006"]}]},{"name":"Programa de Suport als Grups de Recerca AGAUR","award":["CB21\/13\/00020"],"award-info":[{"award-number":["CB21\/13\/00020"]}]},{"name":"SPANISH AIDS Research Network","award":["PI16\/00503"],"award-info":[{"award-number":["PI16\/00503"]}]},{"name":"SPANISH AIDS Research Network","award":["PI19\/01337"],"award-info":[{"award-number":["PI19\/01337"]}]},{"name":"SPANISH AIDS Research Network","award":["PI20\/00326"],"award-info":[{"award-number":["PI20\/00326"]}]},{"name":"SPANISH AIDS Research Network","award":["2017SGR948"],"award-info":[{"award-number":["2017SGR948"]}]},{"name":"SPANISH AIDS Research Network","award":["RD16\/0025\/0006"],"award-info":[{"award-number":["RD16\/0025\/0006"]}]},{"name":"SPANISH AIDS Research Network","award":["CB21\/13\/00020"],"award-info":[{"award-number":["CB21\/13\/00020"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["PI16\/00503"],"award-info":[{"award-number":["PI16\/00503"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["PI19\/01337"],"award-info":[{"award-number":["PI19\/01337"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["PI20\/00326"],"award-info":[{"award-number":["PI20\/00326"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["2017SGR948"],"award-info":[{"award-number":["2017SGR948"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["RD16\/0025\/0006"],"award-info":[{"award-number":["RD16\/0025\/0006"]}]},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas-ISCIII","award":["CB21\/13\/00020"],"award-info":[{"award-number":["CB21\/13\/00020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Nuclear magnetic resonance (NMR)-based advanced lipoprotein tests have demonstrated that LDL and HDL particle numbers (LDL-P and HDL-P) are more powerful cardiovascular (CV) risk biomarkers than conventional cholesterol markers. Of interest, in people living with HIV (PLHIV), predictors of preclinical atherosclerosis and vascular dysfunction may be associated with impaired immune function. We previously stated that immunological non-responders (INR) were at higher CV risk than immunological responders (IR) before starting antiretroviral therapy (ART). Using Liposcale\u00ae tests, we characterized the lipoprotein profile from the same cohort of PLHIV at month 12 and month 36 after starting ART, intending to explore what happened with these indicators of CV risk during viral suppression. ART initiation dissipates the differences in lipoprotein-based CV risk markers between INR and IR, and only an increase in the number of HDL-P was found in INR + IR when compared to controls (p = 0.047). Interestingly, CD4+ T-cell counts negatively correlated with medium HDL-P concentrations at month 12 in all individuals (\u03c1 = \u22120.335, p = 0.003). Longitudinal analyses showed an important increase in LDL-P and HDL-P at month 36 when compared to baseline values in both IR and INR. A proper balance between a proatherogenic and atherogenic environment may be related to the reconstitution of CD4+ T-cell count in PLHIV.<\/jats:p>","DOI":"10.3390\/ijms23158071","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:53:45Z","timestamp":1658494425000},"page":"8071","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lipoprotein Profile in Immunological Non-Responders PLHIV after Antiretroviral Therapy Initiation"],"prefix":"10.3390","volume":"23","author":[{"given":"Jenifer","family":"Masip","sequence":"first","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-4340","authenticated-orcid":false,"given":"Rosa","family":"Jorba","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-2523","authenticated-orcid":false,"given":"Miguel","family":"L\u00f3pez-Dupla","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5770","authenticated-orcid":false,"given":"Pere","family":"Domingo","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda Mar\u00eda","family":"Pacheco","sequence":"additional","affiliation":[{"name":"Immunology Lab, Institute of Biomedicine of Seville, University Hospital Virgen del Roc\u00edo\/CSIC\/University of Seville, 41013 Seville, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graciano","family":"Garc\u00eda-Pardo","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"},{"name":"Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, 08036 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Consuelo","family":"Vilad\u00e9s","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Veloso","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Alba","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Olona","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Vidal","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"G\u00f3mez-Bertomeu","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquim","family":"Peraire","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8907-7754","authenticated-orcid":false,"given":"Anna","family":"Rull","sequence":"additional","affiliation":[{"name":"Infection and Immunity Research Group (INIM), Universitat Rovira i Virgili, 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Institut Investigaci\u00f3 Sanit\u00e0ria Pere Virgili (IISPV), 43003 Tarragona, Spain"},{"name":"Infection and Immunity Research Group (INIM), Hospital Universitari de Tarragona Joan XXIII, 43005 Tarragona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QAI.0b013e3181b033ab","article-title":"Incidence of Non-AIDS-Defining Malignancies in HIV-Infected versus Noninfected Patients in the HAART Era: Impact of Immunosuppression","volume":"52","author":"Bedimo","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/596766","article-title":"Changes in Cancer Mortality among HIV-Infected Patients: The Mortalit\u00e9 2005 Survey","volume":"48","author":"Bonnet","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global Burden of Atherosclerotic Cardiovascular Disease in People Living with the Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/COH.0b013e3282fb7bcf","article-title":"Antiretroviral Therapy as a Cardiovascular Disease Risk Factor: Fact or Fiction? A Review of Clinical and Surrogate Outcome Studies","volume":"3","author":"Smieja","year":"2008","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The End of AIDS: HIV Infection as a Chronic Disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a Novel Marker of Activated Macrophages, Is Elevated and Associated with Noncalcified Coronary Plaque in HIV-Infected Patients","volume":"204","author":"Burdo","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/QAD.0b013e328300581d","article-title":"Low CD4+ T-Cell Count as a Major Atherosclerosis Risk Factor in HIV-Infected Women and Men","volume":"22","author":"Kaplan","year":"2008","journal-title":"AIDS"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/QAD.0000000000001730","article-title":"A Baseline Metabolomic Signature Is Associated with Immunological CD4+ T-Cell Recovery after 36 Months of Antiretroviral Therapy in HIV-Infected Patients","volume":"32","author":"Pacheco","year":"2018","journal-title":"AIDS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1093\/eurheartj\/ehs020","article-title":"High-Throughput Quantification of Circulating Metabolites Improves Prediction of Subclinical Atherosclerosis","volume":"33","author":"Raiko","year":"2012","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature06802","article-title":"The Search for New Cardiovascular Biomarkers","volume":"451","author":"Gerszten","year":"2008","journal-title":"Nature"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1194\/jlr.D050120","article-title":"Liposcale: A Novel Advanced Lipoprotein Test Based on 2D Diffusion-Ordered 1H NMR Spectroscopy","volume":"56","author":"Mallol","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpcardio0719","article-title":"Should Advanced Lipoprotein Testing Be Used in Clinical Practice?","volume":"3","author":"Stein","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MED.0b013e32835ed9cb","article-title":"Update on the Detection and Treatment of Atherogenic Low-Density Lipoproteins","volume":"20","author":"Sniderman","year":"2013","journal-title":"Curr. Opin. Endocrinol. Diabetes. Obes."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-150-7-200904070-00007","article-title":"Systematic Review: Association of Low-Density Lipoprotein Subfractions with Cardiovascular Outcomes","volume":"150","author":"Ip","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2012.03.060","article-title":"High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"60","author":"MacKey","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"H599","DOI":"10.1152\/ajpheart.00314.2021","article-title":"Sphingosine-1-Phosphate Interactions in the Spleen and Heart Reflect Extent of Cardiac Repair in Mice and Failing Human Hearts","volume":"321","author":"Gowda","year":"2021","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Liang, C., Gowda, S.G.B., Gowda, D., Sakurai, T., Sazaki, I., Chiba, H., and Hui, S.P. (2022). Simple and Sensitive Method for the Quantitative Determination of Lipid Hydroperoxides by Liquid Chromatography\/Mass Spectrometry. Antioxidants, 11.","DOI":"10.3390\/antiox11020229"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1758-2652-14-37","article-title":"Metabolic and Anthropometric Parameters Contribute to ART-Mediated CD4+ T Cell Recovery in HIV-1-Infected Individuals: An Observational Study","volume":"14","author":"Azzoni","year":"2011","journal-title":"J. Int. AIDS Soc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1042\/CS20190111","article-title":"Glutaminolysis and Lipoproteins Are Key Factors in Late Immune Recovery in Successfully Treated HIV-Infected Patients","volume":"133","author":"Peraire","year":"2019","journal-title":"Clin. Sci."},{"key":"ref_21","first-page":"757","article-title":"Lipoprotein Ratios: Physiological Significance and Clinical Usefulness in Cardiovascular Prevention","volume":"5","author":"Pallardo","year":"2009","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_22","unstructured":"(2022, May 16). Dyslipidemia in the HIV Patient\u2014Infectious Disease Advisor. Available online: https:\/\/www.infectiousdiseaseadvisor.com\/home\/decision-support-in-medicine\/infectious-diseases\/dyslipidemia-in-the-hiv-patient\/."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijcard.2018.03.128","article-title":"LDL Particle Size and Composition and Incident Cardiovascular Disease in a South-European Population: The Hortega-Liposcale Follow-up Study","volume":"264","author":"Pichler","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL Particle Number and Size as Predictors of Cardiovascular Disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0002-9149(02)02427-X","article-title":"Relations of Lipoprotein Subclass Levels and Low-Density Lipoprotein Size to Progression of Coronary Artery Disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) Trial","volume":"90","author":"Rosenson","year":"2002","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8071\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:54:43Z","timestamp":1760140483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/15\/8071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":25,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["ijms23158071"],"URL":"https:\/\/doi.org\/10.3390\/ijms23158071","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]}}}